Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea

Medical Care

Volumn 49, Issue 4, 2011, Pages 378-384

  Hong, Jae Seok ^a   Kang, Hee Chung ^a  

^a Health Insurance Review Agency   (South Korea)

Author keywords

Adherence to medication; Anti diabetic drugs; Health care costs; Hospitalization; Mortality; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; MEGLITINIDE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA;

EID: 85027946406     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31820292d1     Document Type: Article

References (26)

1. World Health Organization. World Health Report. Geneva: World Health Organization; 2008:8. Available at: http://www.who.int/whr/2008/en/index.html.
2. Kim J. Diabetes in Korea 2007. Seoul, South Korea: Health Insurance Review and Assessment Service, Korean Diabetes Association; 2007.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
5. Lau DT, Nau DP. Oral anti hyperglycemic medication non adherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153. (Pubitemid 39167177)
6. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication non adherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-1841. (Pubitemid 44455165)
7. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530. (Pubitemid 40847288)
8. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated healthcare costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958-2971. (Pubitemid 37510603)
9. International Diabetes Federation. Diabetes Atlas. 2nd ed. Brussels, Belgium: International Diabetes Federation; 2003.
10. Hong JS, Kang HC, Kim J. Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and COPD in Korea. J Korean Med Sci. 2010;25:1259-1271.
11. Gill JM, Mainous AG III. The role of provider continuity in preventing hospitalizations. Arch Fam Med. 1998;7:352-357. (Pubitemid 128433257)
12. Mainous AG III, Gill JM. The importance of continuity of care in the likelihood of future hospitalization: is site of care equivalent to a primary clinician? Am J Public Health. 1998;88:1539-1541. (Pubitemid 28455765)
13. Korean Diabetes Association. Treatment Guideline for Diabetes. 1st ed. Seoul, South Korea: MMK Communications; 2007.
14. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288. (Pubitemid 44204957)
15. Karve S, Cleves MA, Helm M, et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46:1125-1133.
16. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-1224. (Pubitemid 38579798)
17. Duncan JC, Rogers R. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders. J Forensic Sci. 1998;43:1133-1137. (Pubitemid 28554808)
18. Gary TL, Crum RM, Cooper-Patrick L, et al. Depressive symptoms and metabolic control in African Americans with type 2 diabetes. Diabetes Care. 2000;23:23-29. (Pubitemid 30022889)
19. Skaer TL, Sclar DA, Markowski DJ, et al. Effect of value-added utilities on prescription refill compliance and Medicaid healthcare expendituresa study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther. 1993;18:295-299. (Pubitemid 23235099)
20. Center for Chronic Disease Preventive and Control. Diabetes in Canada. 2nd ed. Health Canada, Public Health Agency of Canada; 2003. Available at: http://www.phac-aspc.gc.ca/publicat/dic-dac2/english/01cover-eng.php.
21. American Diabetes Association. Standard of medical care in diabetes. Diabetes Care. 2004;27:S15-S35.
22. Kim J, Kim H, Min KW, et al. Current status of the continuity of ambulatory diabetes care and its impact on health outcomes and medical cost in Korea using National Health Insurance Database. J Korean Diabetes. 2006;30:377-387.
23. Lee WC, Balu S, Cobden D, et al. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006;19:31-41. (Pubitemid 44148014)
24. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021. (Pubitemid 41110487)
25. Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on healthcare costs and utilization. JAMA. 2001;285:182-189. (Pubitemid 32048520)
26. Hong JS, Kang HC. Oral anti hyperglycemic medication adherence and its associated factors among ambulatory care with adult type 2 diabetes patients in Korea. Korean J Health Policy Adm. 2010;20:128-143.